Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 511

1.

Modifiable Risk Factors Explain Socioeconomic Inequalities in Dementia Risk: Evidence from a Population-Based Prospective Cohort Study.

Deckers K, Cadar D, van Boxtel MPJ, Verhey FRJ, Steptoe A, Köhler S.

J Alzheimers Dis. 2019 Aug 14. doi: 10.3233/JAD-190541. [Epub ahead of print]

PMID:
31424404
2.

"In vivo imaging of the nucleus of the solitary tract with Magnetization Transfer at 7 Tesla".

Priovoulos N, Poser BA, Ivanov D, Verhey FR, Jacobs HI.

Neuroimage. 2019 Aug 6:116071. doi: 10.1016/j.neuroimage.2019.116071. [Epub ahead of print]

PMID:
31398435
3.

Optimal Detection of Subtle Gadolinium Leakage in CSF with Heavily T2-Weighted Fluid-Attenuated Inversion Recovery Imaging.

Freeze WM, Ter Weele DN, Palm WM, van Hooren RW, Hoff EI, Jansen JFA, Jacobs HIL, Verhey FR, Backes WH.

AJNR Am J Neuroradiol. 2019 Aug 8. doi: 10.3174/ajnr.A6145. [Epub ahead of print]

PMID:
31395665
4.

Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease.

Bos I, Vos SJB, Schindler SE, Hassenstab J, Xiong C, Grant E, Verhey F, Morris JC, Visser PJ, Fagan AM.

Alzheimers Dement. 2019 Aug 1. pii: S1552-5260(19)30122-0. doi: 10.1016/j.jalz.2019.04.015. [Epub ahead of print]

PMID:
31378575
5.

The necessity for sustainable intervention effects: lessons-learned from an experience sampling intervention for spousal carers of people with dementia.

Bartels SL, van Knippenberg RJM, Köhler S, Ponds RW, Myin-Germeys I, Verhey FRJ, de Vugt ME.

Aging Ment Health. 2019 Aug 1:1-11. doi: 10.1080/13607863.2019.1647130. [Epub ahead of print]

PMID:
31368355
6.

Association Between Proxy- or Self-Reported Cognitive Decline and Cognitive Performance in Memory Clinic Visitors.

Gruters AAA, Ramakers IHGB, Verhey FRJ, Köhler S, Kessels RPC, de Vugt ME.

J Alzheimers Dis. 2019 Jul 12. doi: 10.3233/JAD-180857. [Epub ahead of print]

PMID:
31322557
7.

Cognitive and functional progression of dementia in two longitudinal studies.

Wang Y, Haaksma ML, Ramakers IHGB, Verhey FRJ, van de Flier WM, Scheltens P, van Maurik I, Olde Rikkert MGM, Leoutsakos JS, Melis RJF.

Int J Geriatr Psychiatry. 2019 Jul 18. doi: 10.1002/gps.5175. [Epub ahead of print]

PMID:
31318090
8.

Optimizing access to and use of formal dementia care: Qualitative findings from the European Actifcare study.

Kerpershoek L, Wolfs C, Verhey F, Jelley H, Woods B, Bieber A, Bartoszek G, Stephan A, Selbaek G, Eriksen S, Sjölund BM, Hopper L, Irving K, MSc PhD M, Gonçalves-Pereira M, Portolani D, Zanetti O, Vugt M; Actifcare Consortium.

Health Soc Care Community. 2019 Jul 10. doi: 10.1111/hsc.12804. [Epub ahead of print]

PMID:
31293018
9.

[Needs for Care and Service Use in Dementia: Baseline Assessment of Portuguese Participants in the Actifcare Cohort Study].

Gonçalves-Pereira M, Marques MJ, Balsinha C, Fernandes A, Machado AS, Verdelho A, Barahona-Corrêa B, Bárrios H, Guimarães J, Grave J, Alves L, Almeida MC, Reis TA, Orrell M, Woods B, De Vugt M, Verhey F; Actifcare Consortium.

Acta Med Port. 2019 May 31;32(5):355-367. doi: 10.20344/amp.11136. Epub 2019 May 31. Portuguese.

10.

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.

Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups.

Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.

PMID:
31164314
11.

Dementia awareness and risk perception in middle-aged and older individuals: baseline results of the MijnBreincoach survey on the association between lifestyle and brain health.

Heger I, Deckers K, van Boxtel M, de Vugt M, Hajema K, Verhey F, Köhler S.

BMC Public Health. 2019 Jun 3;19(1):678. doi: 10.1186/s12889-019-7010-z.

12.

Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms.

Jacobs HIL, Riphagen JM, Ramakers IHGB, Verhey FRJ.

Mol Psychiatry. 2019 May 28. doi: 10.1038/s41380-019-0437-x. [Epub ahead of print]

PMID:
31138892
13.

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.

Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, Ten Kate M, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey F, Sala I, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Barkhof F, Ashton N, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C.

Alzheimers Dement. 2019 Jun;15(6):817-827. doi: 10.1016/j.jalz.2019.03.004. Epub 2019 May 8.

14.

Driving Difficulties Among Patients with Alzheimer's Disease and Other Neurodegenerative Disorders.

Fuermaier ABM, Piersma D, de Waard D, Davidse RJ, de Groot J, Doumen MJA, Bredewoud RA, Claesen R, Lemstra AW, Scheltens P, Vermeeren A, Ponds R, Verhey F, De Deyn PP, Brouwer WH, Tucha O.

J Alzheimers Dis. 2019;69(4):1019-1030. doi: 10.3233/JAD-181095.

PMID:
31045516
15.

Development of memory clinics in the Netherlands over the last 20 years.

Gruters AAA, Ramakers IHGB, Kessels RPC, Bouwman FH, Olde Rikkert MGM, Blom MM, de Vugt ME, Verhey FRJ.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1267-1274. doi: 10.1002/gps.5132. Epub 2019 May 20.

PMID:
31034652
16.

Importance of Social Support Within the Nursing Staff on Agitation in Residents With Dementia.

Tan EYL, de Vugt ME, Köhler S, Verhey FRJ, Schols JMGA.

J Am Med Dir Assoc. 2019 Jun;20(6):785-786. doi: 10.1016/j.jamda.2019.03.002. Epub 2019 Apr 16. No abstract available.

PMID:
31003932
17.

Effects on staff outcomes from an intervention for management of neuropsychiatric symptoms in residents of young-onset dementia care units: A cluster randomised controlled trial.

van Duinen-van den IJssel JCL, Bakker C, Smalbrugge M, Zwijsen SA, Appelhof B, Teerenstra S, Zuidema SU, de Vugt ME, Verhey FRJ, Koopmans RTCM.

Int J Nurs Stud. 2019 Aug;96:35-43. doi: 10.1016/j.ijnurstu.2019.03.006. Epub 2019 Mar 15.

PMID:
30979401
18.

Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with young-onset dementia.

Mulders AJMJ, Zuidema SU, Leeuwis R, Bor H, Verhey FRJ, Koopmans RTCM.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1185-1193. doi: 10.1002/gps.5116. Epub 2019 Apr 29.

PMID:
30968446
19.

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.

Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimón J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K.

Alzheimers Dement. 2019 Jun;15(6):742-753. doi: 10.1016/j.jalz.2019.01.015. Epub 2019 Apr 6.

PMID:
30967340
20.

Survival and life-expectancy in a young-onset dementia cohort with six years of follow-up: the NeedYD-study.

Gerritsen AAJ, Bakker C, Verhey FRJ, Pijnenburg YAL, Millenaar JK, de Vugt ME, Koopmans RTCM.

Int Psychogeriatr. 2019 Mar 27:1-9. doi: 10.1017/S1041610219000152. [Epub ahead of print]

PMID:
30915930
21.

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.

Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ.

Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.

PMID:
30853464
22.

Effects of a Multidisciplinary Intervention on the Presence of Neuropsychiatric Symptoms and Psychotropic Drug Use in Nursing Home Residents WithYoung-Onset Dementia: Behavior and Evolution of Young-Onset Dementia Part 2 (BEYOND-II) Study.

Appelhof B, Bakker C, de Vugt ME, van Duinen-van den IJssel JCL, Zwijsen SA, Smalbrugge M, Teerenstra S, Verhey FRJ, Zuidema SU, Koopmans RTCM.

Am J Geriatr Psychiatry. 2019 Jun;27(6):581-589. doi: 10.1016/j.jagp.2018.12.032. Epub 2019 Jan 4.

PMID:
30799167
23.

Greater Blood Pressure Variability Is Associated With Lower Cognitive Performance.

Zhou TL, Kroon AA, van Sloten TT, van Boxtel MPJ, Verhey FRJ, Schram MT, Köhler S, Stehouwer CDA, Henry RMA.

Hypertension. 2019 Apr;73(4):803-811. doi: 10.1161/HYPERTENSIONAHA.118.12305.

PMID:
30739535
24.

Relationship quality and sense of coherence in dementia: Results of a European cohort study.

Marques MJ, Woods B, Hopper L, Jelley H, Irving K, Kerpershoek L, Meyer G, Bieber A, Stephan A, Sköldunger A, Sjölund BM, Selbaek G, Rosvik J, Zanetti O, Portolani E, de Vugt M, Verhey F, Gonçalves-Pereira M; Actifcare Consortium.

Int J Geriatr Psychiatry. 2019 May;34(5):745-755. doi: 10.1002/gps.5082. Epub 2019 Mar 11.

PMID:
30729572
25.

Depressive Symptoms in Mild Cognitive Impairment and the Risk of Dementia: A Systematic Review and Comparative Meta-Analysis of Clinical and Community-Based Studies.

Tan EYL, Köhler S, Hamel REG, Muñoz-Sánchez JL, Verhey FRJ, Ramakers IHGB.

J Alzheimers Dis. 2019;67(4):1319-1329. doi: 10.3233/JAD-180513.

PMID:
30689564
26.

Interventions to enhance access to and utilization of formal community care services for home dwelling persons with dementia and their informal carers. A scoping review.

Røsvik J, Michelet M, Engedal K, Bieber A, Broda A, Gonçalves-Pereira M, Hopper L, Irving K, Jelley H, Kerpershoek L, Meyer G, Marques MJ, Portolani E, Sjölund BM, Sköldunger A, Stephan A, Verhey F, de Vugt M, Woods B, Wolfs C, Zanetti O, Selbaek G.

Aging Ment Health. 2019 Jan 21:1-12. doi: 10.1080/13607863.2018.1523876. [Epub ahead of print]

PMID:
30663890
27.

The clinical course and interrelations of dementia related symptoms - CORRIGENDUM.

Haaksma ML, Leoutsakos JS, Bremer JAE, Aalten P, Ramakers IHGB, Verhey FRJ, Olde Rikkert MGM, Melis RJF.

Int Psychogeriatr. 2018 Dec 6:1. doi: 10.1017/S1041610218001771. [Epub ahead of print] No abstract available.

PMID:
30520402
28.

Do caregiver profiles predict the use of dementia care services? Findings from the Actifcare study.

Kerpershoek L, Woods B, Wolfs C, Verhey F, Jelley H, Bieber A, Stephan A, Michelet M, Selbaek G, Handels R, Wimo A, Hopper L, Irving K, Marques MJ, Gonçalves-Pereira M, Portolani E, Zanetti O, de Vugt M; and the Actifcare Consortium.

Aging Ment Health. 2018 Dec 6:1-8. doi: 10.1080/13607863.2018.1544215. [Epub ahead of print]

PMID:
30518244
29.

Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study.

Deckers K, Nooyens A, van Boxtel M, Verhey F, Verschuren M, Köhler S.

J Alzheimers Dis. 2019;70(s1):S31-S41. doi: 10.3233/JAD-180492.

PMID:
30507570
30.

Apolipoprotein E and affective symptoms in mild cognitive impairment and Alzheimer's disease dementia: A systematic review and meta-analysis.

Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P.

Neurosci Biobehav Rev. 2019 Jan;96:302-315. doi: 10.1016/j.neubiorev.2018.11.020. Epub 2018 Dec 1.

31.

Process evaluation of a social support platform 'Inlife' for caregivers of people with dementia.

Dam AEH, Christie HL, Smeets CMJ, van Boxtel MPJ, Verhey FRJ, de Vugt ME.

Internet Interv. 2018 Nov 3;15:18-27. doi: 10.1016/j.invent.2018.09.002. eCollection 2019 Mar.

32.

Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage.

Freeze WM, Jacobs HIL, Schreuder FHBM, van Oostenbrugge RJ, Backes WH, Verhey FR, Klijn CJM.

Front Neurol. 2018 Nov 12;9:926. doi: 10.3389/fneur.2018.00926. eCollection 2018.

33.

Anxiety as a Risk Factor for Cognitive Decline: A 12-Year Follow-Up Cohort Study.

Gulpers BJA, Oude Voshaar RC, van Boxtel MPJ, Verhey FRJ, Köhler S.

Am J Geriatr Psychiatry. 2019 Jan;27(1):42-52. doi: 10.1016/j.jagp.2018.09.006. Epub 2018 Sep 14.

PMID:
30409551
34.

Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia.

Janssen N, Handels RL, Sköldunger A, Woods B, Jelley H, Edwards RT, Orrell M, Selbæk G, Røsvik J, Gonçalves-Pereira M, Marques MJ, Zanetti O, Portolani E, Irving K, Hopper L, Meyer G, Bieber A, Stephan A, Kerpershoek L, Wolfs CAG, de Vugt ME, Verhey FRJ, Wimo A; Consortium Actifcare.

J Alzheimers Dis. 2018;66(3):1165-1174. doi: 10.3233/JAD-180531.

PMID:
30400096
35.

The MMSE should not be the sole indicator of fitness to drive in mild Alzheimer's dementia.

Piersma D, Fuermaier ABM, de Waard D, De Deyn PP, Davidse RJ, de Groot J, Doumen MJA, Bredewoud RA, Claesen R, Lemstra AW, Vermeeren A, Ponds R, Verhey F, Brouwer WH, Tucha O.

Acta Neurol Belg. 2018 Dec;118(4):637-642. doi: 10.1007/s13760-018-1036-3. Epub 2018 Nov 2.

36.

A comparison of self and proxy quality of life ratings for people with dementia and their carers: a European prospective cohort study.

O'Shea E, Hopper L, Marques M, Gonçalves-Pereira M, Woods B, Jelley H, Verhey F, Kerpershoek L, Wolfs C, de Vugt M, Stephan A, Bieber A, Meyer G, Wimo A, Michelet M, Selbaek G, Portolani E, Zanetti O, Irving K; Actifcare Consortium.

Aging Ment Health. 2018 Nov 1:1-9. doi: 10.1080/13607863.2018.1517727. [Epub ahead of print]

PMID:
30381955
37.

Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.

Handels RLH, Sköldunger A, Bieber A, Edwards RT, Gonçalves-Pereira M, Hopper L, Irving K, Jelley H, Kerpershoek L, Marques MJ, Meyer G, Michelet M, Portolani E, Røsvik J, Selbaek G, Stephan A, de Vugt M, Wolfs C, Woods B, Zanetti O, Verhey F, Wimo A; and Actifcare consortium.

J Alzheimers Dis. 2018;66(3):1027-1040. doi: 10.3233/JAD-180275.

PMID:
30372674
38.

Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.

Müller-Ehrenberg L, Riphagen JM, Verhey FRJ, Sack AT, Jacobs HIL; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2018;66(2):811-823. doi: 10.3233/JAD-180676.

PMID:
30320590
39.

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.

Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, Engelborghs S, Van Broeckhoven C, Martinez-Lage P, Popp J, Tsolaki M, Verhey FRJ, Baird AL, Legido-Quigley C, Bertram L, Dobricic V, Zetterberg H, Lovestone S, Streffer J, Bianchetti S, Novak GP, Revillard J, Gordon MF, Xie Z, Wottschel V, Frisoni G, Visser PJ, Barkhof F.

Alzheimers Res Ther. 2018 Sep 27;10(1):100. doi: 10.1186/s13195-018-0428-1.

40.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

41.

A systematic review on the implementation of eHealth interventions for informal caregivers of people with dementia.

Christie HL, Bartels SL, Boots LMM, Tange HJ, Verhey FJJ, de Vugt ME.

Internet Interv. 2018 Jul 7;13:51-59. doi: 10.1016/j.invent.2018.07.002. eCollection 2018 Sep. Review.

42.

The Impact of Frailty and Comorbidity on Institutionalization and Mortality in Persons With Dementia: A Prospective Cohort Study.

Haaksma ML, Rizzuto D, Ramakers IHGB, Garcia-Ptacek S, Marengoni A, van der Flier WM, Verhey FRJ, Olde Rikkert MGM, Melis RJF.

J Am Med Dir Assoc. 2019 Feb;20(2):165-170.e2. doi: 10.1016/j.jamda.2018.06.020. Epub 2018 Aug 23.

PMID:
30145169
43.

An Experience Sampling Method Intervention for Dementia Caregivers: Results of a Randomized Controlled Trial.

van Knippenberg RJM, de Vugt ME, Ponds RW, Myin-Germeys I, Verhey FRJ.

Am J Geriatr Psychiatry. 2018 Dec;26(12):1231-1243. doi: 10.1016/j.jagp.2018.06.004. Epub 2018 Jun 21.

PMID:
30126766
44.

[Treatment of hypoactive delirium: is there a place for antipsychotics?]

van Velthuijsen EL, Zwakhalen SMG, Kempen GIJM, Verhey FRJ.

Ned Tijdschr Geneeskd. 2018 Jul 13;162. pii: D2660. Dutch.

PMID:
30040299
45.
46.

Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.

Bos I, Vos SJB, Jansen WJ, Vandenberghe R, Gabel S, Estanga A, Ecay-Torres M, Tomassen J, den Braber A, Lleó A, Sala I, Wallin A, Kettunen P, Molinuevo JL, Rami L, Chetelat G, de la Sayette V, Tsolaki M, Freund-Levi Y, Johannsen P; Alzheimer's Disease Neuroimaging Initiative, Novak GP, Ramakers I, Verhey FR, Visser PJ.

Front Aging Neurosci. 2018 Jun 25;10:193. doi: 10.3389/fnagi.2018.00193. eCollection 2018.

47.

Personality traits and course of symptoms of depression and apathy after stroke: Results of the CASPER study.

Douven E, Staals J, Schievink SHJ, van Oostenbrugge RJ, Verhey FRJ, Wetzels-Meertens S, Köhler S, Aalten P.

J Psychosom Res. 2018 Aug;111:69-75. doi: 10.1016/j.jpsychores.2018.05.010. Epub 2018 May 21.

PMID:
29935757
48.

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.

Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Rikkert MO, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB.

Alzheimers Res Ther. 2018 Jun 20;10(1):56. doi: 10.1186/s13195-018-0391-x.

49.

Barriers and facilitators to the access to and use of formal dementia care: findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries.

Stephan A, Bieber A, Hopper L, Joyce R, Irving K, Zanetti O, Portolani E, Kerpershoek L, Verhey F, de Vugt M, Wolfs C, Eriksen S, Røsvik J, Marques MJ, Gonçalves-Pereira M, Sjölund BM, Jelley H, Woods B, Meyer G; Actifcare Consortium.

BMC Geriatr. 2018 Jun 4;18(1):131. doi: 10.1186/s12877-018-0816-1.

50.

Shades of white: diffusion properties of T1- and FLAIR-defined white matter signal abnormalities differ in stages from cognitively normal to dementia.

Riphagen JM, Gronenschild EHBM, Salat DH, Freeze WM, Ivanov D, Clerx L, Verhey FRJ, Aalten P, Jacobs HIL.

Neurobiol Aging. 2018 Aug;68:48-58. doi: 10.1016/j.neurobiolaging.2018.03.029. Epub 2018 Apr 5.

Supplemental Content

Loading ...
Support Center